NF2, moesin-ezrin-radixin like (MERLIN) tumour suppressor
Ultimo aggiornamento 17 Apr 2023
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Versione audio
- Aggiungi alle fonti preferite su Google
L NF2 gene provides instructions for the production of a protein called merlin, also known as schwannomin. This protein is made in the nervous system, particularly in specialized cells called Schwann cells that wrap around and insulate nerves.
Normal function
L NF2 gene provides instructions for the production of a protein called merlin, also known as schwannomin. This protein is made in the nervous system, particularly in specialized cells called Schwann cells that wrap around and insulate nerves.
Merlin helps regulate several key signaling pathways that are important for controlling cell shape, cell growth, and the attachment of cells to one another (cell adhesion). This protein functions as a tumour suppressor, preventing cells from growing and dividing too fast or in an uncontrolled way.
Conditions referring to this gene or chromosome
Altri nomi
ACN
BANF
MERL_HUMAN
merlin
moesin-ezrin-radixin-like protein
SCH
schwannomerlin
schwannomin
Related patient information and medicines
Patient information leaflet
Neuroma acustico
Un neuroma acustico is a rare non-cancerous tumour in the brain. The tumour grows on a nerve in the b... In fewer than 1 in 10 people, an acoustic neuroma is caused by neurofibromatosis type 2 (NF2). NF2 is a very rare genetic disorder that causes non-cancerous (benign) tumours of the nervous system. People with NF2 can also develop benign tumours.
Patient information leaflet
Cancro al seno
Se cancro al seno è diagnosticati at an early stage, less treatment may be needed and it is more likely to be effective. In general, the more advanced the cancer (the more it has grown and spread), the less chance that treatment will be curative. However, treatments are improving all the time and they can often slow the progress of the cancer. Breast.
Patient information leaflet
Cancro primario al fegato
In secondary liver cancer, dello cancer spreads from another part of the body to the liver. In the UK, most cases develop as a complication of scarring of the liver (cirrhosis). Surgery to remove the cancer is an option in a small number of cases and, if it is possible, gives the best chance of a cure. In the UK, primary liver cancer is uncommon..
Patient information leaflet
Cancro del rene
Se kidney cancer is diagnosed at an early stage, there is a good chance of a cure. Renal cell cancer This type of cancer develops from a cell in a kidney tubule, which becomes cancerous (malignant). The cancer grows and forms into a tumour within the kidney. As the tumour grows: The affected kidney tends to become larger. In time the tumour may.
Patient information leaflet
Polipi nasali
Polipi nasali sono fleshy swellings that grow inside the nose or sinuses. They are usually non-cancerous (benign). The most common symptoms they cause are a stuffy, runny nose. Steroid nasal drops are commonly used to shrink the polyps. Surgical removal of polyps is sometimes needed. Nasal polyps often return after treatment, so steroid nasal sprays.
Patient information leaflet
Trattamento del cancro
Opzioni di trattamento vary, depending on the type of cancer and how far it has grown and spread. The main types are surgery, chemotherapy and radiotherapy. What are the treatment options for cancer. Treatment options vary, depending on the type of cancer and how far it has grown and spread. See the separate leaflets on the specific cancers for more.
Ulteriori letture e riferimenti
- NF2, moesin-ezrin-radixin like (MERLIN) tumour suppressor; MedlinePlus, National Library of Medicine.
- Ahronowitz I, Xin W, Kiely R, Sims K, MacCollin M, Nunes FP. Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings. Hum Mutat. 2007 Jan;28(1):1-12. doi: 10.1002/humu.20393.
- Cooper J, Giancotti FG. Molecular insights into NF2/Merlin tumor suppressor function. FEBS Lett. 2014 Aug 19;588(16):2743-52. doi: 10.1016/j.febslet.2014.04.001. Epub 2014 Apr 12.
- Hadfield KD, Newman WG, Bowers NL, Wallace A, Bolger C, Colley A, McCann E, Trump D, Prescott T, Evans DG. Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis. J Med Genet. 2008 Jun;45(6):332-9. doi: 10.1136/jmg.2007.056499. Epub 2008 Feb 19.
- MacCollin M, Willett C, Heinrich B, Jacoby LB, Acierno JS Jr, Perry A, Louis DN. Familial schwannomatosis: exclusion of the NF2 locus as the germline event. Neurology. 2003 Jun 24;60(12):1968-74. doi: 10.1212/01.wnl.0000070184.08740.e0.
- Petrilli AM, Fernandez-Valle C. Role of Merlin/NF2 inactivation in tumor biology. Oncogene. 2016 Feb 4;35(5):537-48. doi: 10.1038/onc.2015.125. Epub 2015 Apr 20.
- Schroeder RD, Angelo LS, Kurzrock R. NF2/merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations. Oncotarget. 2014 Jan 15;5(1):67-77. doi: 10.18632/oncotarget.1557.
Partecipa alla conversazione
Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.
Chiedi, condividi, connettiti.
Esplora le discussioni, fai domande e condividi esperienze su centinaia di argomenti di salute.
Iscriviti alla newsletter di Patient
La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.
Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.